Search Media Items

NINDS Clinical Director Dr. Avindra Nath meets with clinical trial participant Mr. John Michael. Dr. Nath and his research team are conducting an NIH study to better understand amyotrophic lateral sclerosis or ALS. In the video, Mr. Michael shares his experience as a trial participant while Dr. Nath discusses his research. “Ever since being diagnosed in January of ’14, I kind of made it a mission of mine to find out as much as I can, what’s available out there as treatments, trials, and just my way of giving back, whether it helps me directly or somebody who comes after me,” Mr. Michael says.

Choose the type of application you plan to submit from the chart below. Learn about specific submission requirements, and be sure to follow them, as well as the instructions in the application forms and the funding opportunity announcement. The type of application you submit can impact.

Recipients submit regular scientific progress reports, financial reports, invention reports, and final progress reports as part of the management and oversight of their grant awards.

The Application Submission System & Interface for Submission Tracking (ASSIST) system is used to prepare and submit grant applications electronically to NIH and other Public Health Service agencies. Check out this step by step guide for using ASSIST.

The PHS Human Subjects and Clinical Trials Information Form is used to collect information on:.

If you are the recipient of a grant from the NIH, there is a great deal of information that your organization will need in order to be successful stewards of federal funds. The NIH Welcome Wagon Letter provides information and resources for new grantee organizations on how to manage the award. The information provided below is a brief overview of selected monitoring and reporting requirements.

Vitamin D deficiency has been linked to heart disease and type 2 diabetes.

for osteoporosis, a condition that affects more than 10 million people nationwide.

Researchers linked more than 100 genetic regions to schizophrenia, including 83 that were previously unrecognized. The findings may lead to new strategies for treating this serious brain disorder.